Camlin Fine Sciences Ltd — Regulatory Filings 2021

May 29, 2021

==> picture [100 x 31] intentionally omitted <==

29[th] May, 2021

|To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Company Scrip Code: 532834|To,The Manager,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE || Series: EQ| |---|---|

Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ‐ (“SEBI LODR”)

Dear Sir/Madam,

This is to inform that the senior management of the Company will be attending a virtual conference organized by IIFL Securities – (‘IIFL's Agriculture & Chemicals Virtual Conference’), to be held on 31[st] May, 2021 to discuss the financial results of the Company for the quarter ended March 31, 2021 (Q4) with analysts from the investor community.

We request you to take the above on record and the same be treated as compliance under the applicable Regulations of SEBI LODR.

Note: The date of the scheduled call is subject to change due to exigencies on the part of Investors/Company.

Thanking You,

For Camlin Fine Sciences Limited Mandar Godbole Company Secretary & Compliance Officer

==> picture [426 x 57] intentionally omitted <==